Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Stevens

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
British Journal of Anaesthesia|September 26, 2013
Time-dependent modulation of muscarinic m1/m3 receptor signalling by local anaestheticsS Picardi, M F Stevens, K Hahnenkamp, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivativesD F Shi, T D Bradshaw, M S Chua, et al.
Journal of Medicinal Chemistry|May 27, 1994
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetinM F Stevens, C J McCall, P Lelieveld, et al.
Journal of Medicinal Chemistry|September 4, 1992
Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTICP R Lowe, C E Sansom, C H Schwalbe, et al.
Biochimica Et Biophysica Acta|March 16, 1989
Structural studies on bio-active compounds. Part XV. Structure-activity relationships for pyrimethamine and a series of diaminopyrimidine analogues versus bacterial dihydrofolate reductaseC E Sansom, C H Schwalbe, P A Lambert, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapyS P Langdon, J A Hickman, A Gescher, et al.
FEBS Letters|November 21, 1988
Direct 19F NMR observation of the conformational selection of optically active rotamers of the antifolate compound fluoronitropyrimethamine bound to the enzyme dihydrofolate reductaseS J Tendler, R J Griffin, B Birdsall, et al.
Cancer Research|September 15, 1989
Metabolism and murine pharmacokinetics of the 8-(N,N-dimethylcarboxamide) analogue of the experimental antitumor drug mitozolomide (NSC353451)K R Horspool, C P Quarterman, J A Slack, et al.
British Journal of Cancer|March 26, 1998
2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activityT D Bradshaw, S Wrigley, D F Shi, et al.
Biochemical Pharmacology|October 15, 1983
The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051)P G Cooksey, E N Gate, A Gescher, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
British Journal of Anaesthesia|September 26, 2013
Time-dependent modulation of muscarinic m1/m3 receptor signalling by local anaestheticsS Picardi, M F Stevens, K Hahnenkamp, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivativesD F Shi, T D Bradshaw, M S Chua, et al.
Journal of Medicinal Chemistry|May 27, 1994
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetinM F Stevens, C J McCall, P Lelieveld, et al.
Journal of Medicinal Chemistry|September 4, 1992
Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTICP R Lowe, C E Sansom, C H Schwalbe, et al.
Biochimica Et Biophysica Acta|March 16, 1989
Structural studies on bio-active compounds. Part XV. Structure-activity relationships for pyrimethamine and a series of diaminopyrimidine analogues versus bacterial dihydrofolate reductaseC E Sansom, C H Schwalbe, P A Lambert, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapyS P Langdon, J A Hickman, A Gescher, et al.
FEBS Letters|November 21, 1988
Direct 19F NMR observation of the conformational selection of optically active rotamers of the antifolate compound fluoronitropyrimethamine bound to the enzyme dihydrofolate reductaseS J Tendler, R J Griffin, B Birdsall, et al.
Cancer Research|September 15, 1989
Metabolism and murine pharmacokinetics of the 8-(N,N-dimethylcarboxamide) analogue of the experimental antitumor drug mitozolomide (NSC353451)K R Horspool, C P Quarterman, J A Slack, et al.
British Journal of Cancer|March 26, 1998
2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activityT D Bradshaw, S Wrigley, D F Shi, et al.
Biochemical Pharmacology|October 15, 1983
The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051)P G Cooksey, E N Gate, A Gescher, et al.
Pageof 13